|
HS Code |
108877 |
| Generic Name | Pralidoxime Iodide |
| Chemical Formula | C7H9IN2O |
| Drug Class | Cholinesterase reactivator |
| Indication | Antidote for organophosphate poisoning |
| Route Of Administration | Intramuscular, intravenous |
| Molecular Weight | 264.07 g/mol |
| Appearance | White crystalline powder |
| Storage Temperature | 20°C to 25°C (68°F to 77°F) |
| Mechanism Of Action | Reactivates acetylcholinesterase inhibited by organophosphates |
| Solubility | Freely soluble in water |
| Contraindications | Known hypersensitivity to pralidoxime iodide |
| Half Life | 0.8 to 2.7 hours |
As an accredited Pralidoxime Iodide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a sealed amber glass vial containing 500 mg Pralidoxime Iodide powder, labeled with dosage, manufacturer, and expiry date. |
| Shipping | Pralidoxime Iodide is shipped as a hazardous material, requiring secure, leak-proof packaging and proper labeling according to IATA and DOT regulations. It must be kept dry and protected from light. Shipping documentation includes safety data sheets, and all handlers should use personal protective equipment during transport and handling. |
| Storage | Pralidoxime iodide should be stored in a tightly closed container at controlled room temperature, ideally between 15°C and 30°C (59°F to 86°F), away from moisture, direct sunlight, and incompatible substances. The storage area should be well-ventilated, secure, and clearly labeled, ensuring access only to authorized personnel to prevent accidental exposure or misuse. |
|
Purity 98%: Pralidoxime Iodide with purity 98% is used in organophosphate poisoning treatment scenarios, where it ensures rapid reactivation of inhibited acetylcholinesterase. Particle Size <10 µm: Pralidoxime Iodide with particle size below 10 µm is used in injectable formulations, where it offers enhanced solubility and faster systemic absorption. Stability Temperature up to 40°C: Pralidoxime Iodide stable up to 40°C is used in field emergency kits, where it maintains efficacy under high-temperature storage conditions. Molecular Weight 304.13 g/mol: Pralidoxime Iodide with a molecular weight of 304.13 g/mol is used in pharmacological study protocols, where its defined mass enables precise dosing calculations. Melting Point 200-206°C: Pralidoxime Iodide with a melting point between 200-206°C is used in solid dosage form manufacturing, where it facilitates reliable tableting processes. Moisture Content <1%: Pralidoxime Iodide with moisture content below 1% is used in dry powder for injection products, where it prevents hydrolytic degradation during storage. |
Competitive Pralidoxime Iodide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Pralidoxime Iodide has carved out a unique place among medical antidotes. In critical emergencies—where seconds count and lives hang in the balance—this white crystalline powder often makes the difference between recovery and tragedy. Most folks outside the walls of an emergency department or a military medical unit haven’t likely heard its name. Yet, for anyone dealing with exposure to specific nerve agents or pesticides, Pralidoxime Iodide becomes a hero behind the scenes. The story of how it works and how it's delivered deserves more attention than it usually gets.
The familiar injector filled with Pralidoxime Iodide isn’t just a container of powder—it's a carefully engineered answer to a very specific problem. Health professionals often turn to auto-injectors, designed for use in the field or in the chaos of emergency rooms. Dosing usually delivers a solid 1 gram of the active compound, mixed into an injectable solution, to kick-start the reactivation of acetylcholinesterase. The model has evolved over years of military feedback and civilian crisis response. It’s clear that anyone responding to nerve agent emergencies needs a tool that works with speed, reliability, and simple operation. I know from talking with first responders that they don’t have spare moments to fiddle with finicky vials or fragile ampoules. Pre-measured, single-use delivery makes all the difference when adrenaline is high.
There’s a tendency in the medical supply world to obsess over numbers: weight, purity, consistency, shelf life. While those matter—each dose delivers Pralidoxime Iodide at a concentration that's been tested to restore enzyme activity rapidly—they tell only part of the tale. The real value lives in field experience. Consistent particle size means the powder dissolves smoothly, even under less-than-ideal circumstances, ensuring no time is lost during preparation. Supported by evidence gathered out of actual field deployments, the product remains stable even after unpredictable temperature swings. This kind of resilience builds trust among those who have to use it.
I’ve spent time with EMTs who practiced injections on dummies and watched soldiers run through chemical incident drills. It’s clear that the greatest challenge isn’t memorizing protocols or understanding the underlying science—it’s mastering the quick, no-hesitation movements that save a life. Pralidoxime Iodide delivers its benefit almost instantly after injection, counteracting the effects of organophosphate poisoning. On farms, in enclosed warehouses, and across military conflict zones, the need is the same: rapid reversal of destructive symptoms, restoring muscle control and breathing. I’ve seen teams keep one injector clipped where they keep a tourniquet—practicality and training fuse, turning a vial of powder into an accessible lifeline.
There’s room for skepticism when a product appears on the market: Do the updates matter? Does the model meet the needs of real users? Here, Pralidoxime Iodide stands on firm ground. Rather than simply rebranding or reformatting, improvements over previous generations have focused on rugged packaging, compatibility with existing kits, and resistance to breakage. One field nurse recalled to me how, after years dealing with fragile glass ampoules, the current auto-injectors not only survived her daily rounds but functioned flawlessly beside road dust and bouncing ambulances. The focus remains on what happens far from comfortable hospital storerooms.
It’s fair to ask: What makes this compound stand out from other antidotes, such as Atropine or alternative oximes? Unlike Atropine, which mainly tackles symptoms, Pralidoxime Iodide goes after the underlying biochemical blockage. It restarts the body’s own enzyme process, providing not just relief, but true recovery from poisoning’s root cause. Other oximes, like obidoxime, have their place, yet discrepancies in side-effect profiles and rates of effectiveness make Pralidoxime Iodide a regular favorite among field medics who don’t want to gamble when time is tight. Years of clinical trials and after-action reports have given it a reputation for reliable results, especially for pesticides common in agriculture and nerve agents most likely to see military or homeland security use.
Hospitals and ambulance crews grow particular about which brands and models they trust. Stories circulate about outdated or less sturdy kits failing under pressure. Once, in a regional disaster response class, I handled a variety of antidote injectors. The difference in feel, weight, and sturdiness was impossible to ignore. The injector with Pralidoxime Iodide delivered a smooth, predictable push—no grit, no struggle. Medical supply officers I know look back over years of charting adverse events and downtime, finding that Pralidoxime Iodide consistently works with other resuscitation protocols. Compatibility with Atropine becomes essential; the two products appear alongside each other in virtually every field kit, ready for action.
A product, even one with as strong a track record as Pralidoxime Iodide, only proves its worth in practiced hands. I’ve watched new paramedics struggle on their first few drills, fumbling with ejecting caps and matching needles. The straightforward design streamlines the process, but there’s no substitute for live training. Some years ago, a toxicology instructor I trust spent hours making sure every student understood not just the “how,” but the “why” behind rapid Pralidoxime Iodide delivery. He favored this antidote not because of any lab metric, but because his former students—now seasoned practitioners—kept choosing it in urgent situations.
Every antidote has its own profile of possible complications. Pralidoxime Iodide is no exception. Practitioners report muscle rigidity, blurred vision, increased blood pressure, and headaches in certain cases. Rarely, allergic reactions can occur. While these side effects merit attention, conversations with toxicologists drive home a central point: for victims of organophosphate poisoning, the alternative—untreated neuromuscular breakdown—carries far graver consequences. The clear communication of risks and honest labeling helps providers and patients make informed decisions.
I’ve learned through years in emergency preparedness that no antidote matters if it never leaves the storeroom. Pralidoxime Iodide keeps a strong supply chain, often with government stockpiling backing its distribution. During surges in agricultural poisonings or following public health warnings, reliable logistics ensure hospitals and EMS units don’t face empty shelves. In low-resource settings, NGOs and field teams count on bulk packs that hold up under tough transit conditions. Real-world testimonials show that an effective antidote isn’t only the one that works under a microscope; it’s the one you can load into your pack and deploy on the roadside when a farmworker staggers in from the fields.
Older antidotes often failed the test of speed, stability, or ease of use. I’ve heard from old-school medics about crushed glass vials and lost minutes. Before auto-injectors, precious seconds were spent drawing up a dose from tiny ampoules. Hospitals sometimes ran parallel training sessions: one for ampoule-and-syringe, one for modern injectors. The shift toward pre-filled Pralidoxime Iodide changed those routines overnight. Some medics told me they trust their current kit, partly due to the product’s tamper-evident packaging and partly because of long-standing success rates in metropolitan and rural settings alike.
From rural agricultural centers to crowded cities, preparedness programs all share a commitment to easy, effective antidote deployment. I’ve spoken with public health planners working in pesticide-heavy regions, who make it a priority to keep Pralidoxime Iodide in all their rural clinics. In war zones or in the aftermath of accidental industrial contamination, this compound emerges as a silent linchpin—available, understood, and actionable. Parents of children living near crop fields, or workers moving hazardous chemicals, find relief knowing an antidote with decades of proven results is readily stocked at the nearest health post. Where governments invest in wide-area substance monitoring, Pralidoxime Iodide often heads their recommended countermeasure list.
It’s never enough to simply invent a product and ship it to the warehouse. My experience with community outreach shows that even the best antidote needs to overcome hurdles—costs, misinformation, and legal access. Pralidoxime Iodide’s affordability attracts praise from nonprofit medical programs and rural health providers alike. Local training days in small-town clinics always highlight grants or subsidies aimed at keeping antidote costs feasible for underfunded facilities. In remote regions where supply lines break down or customs delays block critical medicine, partnerships with international relief agencies help bridge the gap. Widespread awareness programs—radio segments, first-responder workshops, and print campaigns—amplify the practical impact of this medication.
Decades of research underpin every dose. Looking across published studies, Pralidoxime Iodide returns high rates of full recovery after organophosphate poisoning when administered promptly with Atropine. Investigators measuring neuro-muscular function usually focus on time-to-reversal and survival rates—metrics that directly impact medical protocols. Speaking to emergency physicians confirms these findings. Most emphasize that the antidote operates within the narrow windows needed to turn a crisis around. No amount of advertising replaces the hard-earned trust that comes from patient files and field case reports. As evidence builds, supply systems adapt by favoring what consistently works.
Climate swings and unpredictable disasters raise new challenges. I spent time advising on disaster kits for rapidly changing environments—floods, wildfires, or heat waves. Medical supplies must resist spoilage even when air conditioning fails or storage facilities flood. Pralidoxime Iodide’s long shelf life and packaging built for rough conditions make it stand out against less sturdy alternatives. This reliability makes it the treatment of choice for regional emergency response caches. Supply coordinators I’ve worked with value low-hassle inventory and the product’s resilience to moderate handling errors.
Access to Pralidoxime Iodide shouldn’t depend on country or income bracket. Over years volunteering with global NGOs, I saw the impact that a lack of effective antidotes can have—families in pesticide-using communities left scrambling or losing loved ones unnecessarily. Programs investing in broad regional distribution paved the way for fewer tragedies and stronger public trust. Ensuring that every hospital, not only big-city centers but also remote outposts, keeps this antidote stocked signals more than compliance: it speaks to a respect for life and fair treatment. Fair pricing strategies and donations prevent economic divides from deciding who gets a second chance.
No health challenge exists in a vacuum. Addressing organophosphate poisoning takes more than antidotes—it needs up-to-date training, regular drills, and collaboration between health sectors. In my experience, regional partnerships between hospitals, fire departments, farming groups, and government regulators lead to the smoothest response during crisis events. National guidelines listing Pralidoxime Iodide as a must-have item push procurement beyond individual clinic budgets, integrating supply into disaster plans. Citizen-focused education campaigns raise awareness about pesticide safety and symptoms, sparking more effective first-response activation.
Medical science isn’t standing still. Ongoing research into faster, more stable oxime antidotes often takes cues from years spent gathering data on Pralidoxime Iodide. Field feedback—sometimes overlooked in top-down discussions—carries weight. Stories from paramedics forced to improvise with damaged kits or clinicians developing rural training programs nudge manufacturers to improve packaging, clarify instructions, and keep safety at the forefront. These ground-level realities ensure that while formulas and delivery systems may change, the product’s practical strengths carry into next-generation solutions.
Over time, trust in a product grows from witnessing real rescues, not just reading about them. Several paramedics I know tell of using Pralidoxime Iodide not just once, but several times throughout their careers—each case reinforcing their confidence. A rural doctor shared the comfort found knowing an effective antidote waited in her refrigerator, even as the nearest city hospital sat hours away. These moments shape the invisible backbone of disaster response: products that don’t just work, but work again and again, no matter the situation.
Building up dependable antidote systems means investing in supply logistics, training, and public trust as much as in chemistry. Each time I attend a crisis medicine seminar, someone shares a story in which Pralidoxime Iodide, ready and easy to use, gave a patient the time needed to reach a higher level of care. That bridge—between initial collapse and recovery—requires reliable products, attentive planning, and informed hands-on experience. All these threads run through the best antidote systems.
Problems don’t wait for business hours, and emergencies ignore tidy supply lines. I’ve grown to believe that keeping products like Pralidoxime Iodide updated, field-proven, and accessible is an ongoing responsibility for medical supply designers, public health leaders, and community advocates alike. Trust builds slowly, case by case. Each time a product stands up to a real-world test, it proves its worth—not in glossy marketing, but in the lived experience of those it protects.